Pasithea Therapeutics Corp. (KTTA) Financials
KTTA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 30.7 million | 2.3 million |
2023-06-30 | 38.1 million | 2.6 million |
2023-03-31 | 42.0 million | 2.9 million |
2022-12-31 | 45.2 million | 2.7 million |
KTTA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.6 million | 126674 |
2023-06-30 | -3.5 million | 218634 |
2023-03-31 | -3.3 million | 177021 |
2022-12-31 | -6.2 million | 156174 |
KTTA Net Income
No data available :(
KTTA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 19.6 million | - | 385288 |
2023-06-30 | 26.6 million | - | 425760 |
2023-03-31 | 29.9 million | - | 465454 |
2022-12-31 | 33.1 million | - | 926887 |
KTTA Shares Outstanding
KTTA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 22659 | 1.6 million | 2.2 million | - |
2023-06-30 | 3108 | 2.0 million | 1.8 million | - |
2023-03-31 | 53888 | 1.1 million | 2.1 million | - |
2022-12-31 | 1.8 million | 1.4 million | 3.9 million | - |
KTTA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 162256 |
2023-06-30 | - | 163217 |
2023-03-31 | - | 162680 |
2022-12-31 | 240712 | 1308 |
KTTA
Price: $7.03
52 week price:
Earnings Per Share: -12.64 USD
P/E Ratio: -0.50
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 51500
Market Capitalization: 8.2 million